Ticker League

Cash on Hand for DexCom (DXCM)

As of · Reported

Metric

Latest period

$2.42B

YoY change

-22.5%

5Y CAGR

-5.9%

Peak year (2021)

$2.73B

Cash on Hand history chart for DexCom (DXCM) from 2000 to 2025

Latest: $2.00B

Cash on Hand growth chart for DexCom (DXCM) from 2000 to 2025

Latest: -22.5%

Cash on Hand history table for DexCom (DXCM) from 2000 to 2025

  • 2025$2.00B-22.5%
  • 2024$2.58B-5.3%
  • 2023$2.72B+10.9%
  • 2022$2.46B-10.1%
  • 2021$2.73B+0.9%
  • 2020$2.71B+76.6%
  • 2019$1.53B+10.7%
  • 2018$1.39B+152.6%
  • 2017$548.60M+343.5%
  • 2016$123.70M+7.4%
  • 2015$115.20M+37.8%
  • 2014$83.60M+53.1%
  • 2013$54.60M+12.1%
  • 2012$48.70M-40.5%
  • 2011$81.91M+73.9%
  • 2010$47.11M+68.2%
  • 2009$28.02M+3.5%
  • 2008$27.07M-57.9%
  • 2007$64.32M+18.0%
  • 2006$54.51M+7.9%
  • 2005$50.52M+85.6%
  • 2004$27.23M+36.0%
  • 2003$20.02M—
  • 2001$7.78M-44.0%
  • 2000$13.90M—

Cash on Hand values are taken from DexCom's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Cash on Hand at DexCom (DXCM)

According to DexCom's latest reported financial statements, the company's latest reported cash and short-term investments is $2.42B. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

2025's annual cash and short-term investments for DexCom (DXCM) came in at $2.00B – declined 22.5% year-over-year.

DexCom cash and short-term investments compound annual growth for the 2020–2025 (5 years) window is -5.9%, with a net decline across the window.

DexCom cash and short-term investments peaked at $2.73B in 2021; the latest annual figure is $2.00B in 2025 (26.8% below peak).

Across the available history, cash and short-term investments reached its high of $2.73B in 2021 and its low of $7.78M in 2001.

DexCom Cash on Hand by Year

DexCom Cash on Hand 2025: $2.00B

DexCom posted cash and short-term investments of $2.00B in 2025, declined 22.5% below 2024.

DexCom Cash on Hand 2024: $2.58B

In 2024, DexCom reported cash and short-term investments of $2.58B, declined 5.3% below 2023.

DexCom Cash on Hand 2023: $2.72B

DexCom cash and short-term investments in 2023 was $2.72B, grew 10.9% from 2022.

DexCom Cash on Hand 2022: $2.46B

2022's cash and short-term investments for DexCom came in at $2.46B, declined 10.1% below 2021.

DexCom Cash on Hand 2021: $2.73B

DexCom cash and short-term investments in 2021 was $2.73B.

See more financial history for DexCom (DXCM).

Sector peers by Cash on Hand

Healthcare peers of DexCom (DXCM), ranked by their latest cash and short-term investments

Frequently asked questions

DexCom (DXCM) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation